doi: 10.1016/0378-1119(88)90596-3.
Biosynthesis and analysis of a genetically engineered HIV-1 reverse transcriptase/endonuclease polyprotein in Escherichia coli
Affiliations
- PMID: 2464529
- DOI: 10.1016/0378-1119(88)90596-3
Item in Clipboard
Biosynthesis and analysis of a genetically engineered HIV-1 reverse transcriptase/endonuclease polyprotein in Escherichia coli
Gene.
.
Abstract
Elimination of the protease domain from the polymerase open reading frame (pol) of the human immunodeficiency virus type 1 (HIV-1) leads, in Escherichia coli, to synthesis and accumulation of a non-processed 98-kDa reverse transcriptase/endonuclease (RT/ENDO) polyprotein. A partially purified preparation of this reverse RT/ENDO polyprotein displays little or no RT activity. Introduction of the pol protease domain as a separate transcriptional unit on the same plasmid restores the processing program, generating correctly sized RT and ENDO polypeptides. Concomitant with restoration of processing is the reappearance of RT activity. These results suggest that for HIV-1 RT to be active, it must be matured from the pol polyprotein.
Similar articles
-
A single 66-kilodalton polypeptide processed from the human immunodeficiency virus type 2 pol polyprotein in Escherichia coli displays reverse transcriptase activity.J Virol. 1988 Jul;62(7):2525-9. doi: 10.1128/JVI.62.7.2525-2529.1988. J Virol. 1988. PMID: 2453682 Free PMC article.
-
Expression, purification, and crystallization of the HIV-1 reverse transcriptase (RT).AIDS Res Hum Retroviruses. 1990 Nov;6(11):1297-303. doi: 10.1089/aid.1990.6.1297. AIDS Res Hum Retroviruses. 1990. PMID: 1706608
-
Organization of HIV-1 pol is critical for Pol polyprotein processing.J Biomed Sci. 1999 Sep-Oct;6(5):333-41. doi: 10.1007/BF02253522. J Biomed Sci. 1999. PMID: 10494040
-
Overproduction of human immunodeficiency virus type I reverse transcriptase in Escherichia coli and purification of the enzyme.Microbiol Immunol. 1990;34(6):509-21. doi: 10.1111/j.1348-0421.1990.tb03168.x. Microbiol Immunol. 1990. PMID: 1699113
-
Purification and characterization of recombinant equine infectious anemia virus reverse transcriptase.J Virol. 1991 Dec;65(12):7004-7. doi: 10.1128/JVI.65.12.7004-7007.1991. J Virol. 1991. PMID: 1719238 Free PMC article.
Cited by
-
Direct interaction of the human cytomegalovirus IE86 protein with the cis repression signal does not preclude TBP from binding to the TATA box.J Virol. 1993 Sep;67(9):5595-604. doi: 10.1128/JVI.67.9.5595-5604.1993. J Virol. 1993. PMID: 8394462 Free PMC article.
-
Illimaquinone, a selective inhibitor of the RNase H activity of human immunodeficiency virus type 1 reverse transcriptase.Antimicrob Agents Chemother. 1990 Oct;34(10):2009-12. doi: 10.1128/AAC.34.10.2009. Antimicrob Agents Chemother. 1990. PMID: 1705412 Free PMC article.
-
Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain.J Virol. 2005 Sep;79(18):11952-61. doi: 10.1128/JVI.79.18.11952-11961.2005. J Virol. 2005. PMID: 16140771 Free PMC article.
-
Expression and frameshifting but extremely inefficient proteolytic processing of the HIV-1 gag and pol gene products in stably transfected rodent cell lines.Virology. 1991 Jul;183(1):215-24. doi: 10.1016/0042-6822(91)90134-w. Virology. 1991. PMID: 2053281 Free PMC article.
-
Human T-cell leukemia virus type 1 reverse transcriptase (RT) originates from the pro and pol open reading frames and requires the presence of RT-RNase H (RH) and RT-RH-integrase proteins for its activity.J Virol. 1998 Aug;72(8):6504-10. doi: 10.1128/JVI.72.8.6504-6510.1998. J Virol. 1998. PMID: 9658093 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
